Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SARS-Coronavirus Nucleocapsid Protein Produkte

(SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N))
Packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. {ECO:0000250|UniProtKB:P03417, ECO:0000269|PubMed:17210170}.

antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.

Ausgewählte SARS-Coronavirus Nucleocapsid Protein Kategorien

SARS-Coronavirus Nucleocapsid Protein Antikörper

High quality antibodies with extensive validation data.

SARS-Coronavirus Nucleocapsid Protein Proteine

Proteins for various applications incl. WB, ELISA, IF etc.

Empfohlene SARS-Coronavirus Nucleocapsid Protein Antikörper

Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
Applikation ELISA, WB, FACS, FM, IHC
Validierungen
  • (96)
  • (14)
Kat. Nr. ABIN6952544
Menge 500 μg
Datenblatt Datenblatt
Reaktivität SARS Coronavirus (SARS-CoV)
Applikation ELISA, WB
Validierungen
  • (1)
Kat. Nr. ABIN6952441
Menge 100 μL
Datenblatt Datenblatt
Reaktivität SARS Coronavirus (SARS-CoV)
Applikation ELISA, WB
Validierungen
Kat. Nr. ABIN7383874
Menge 50 μL
Datenblatt Datenblatt

Empfohlene SARS-Coronavirus Nucleocapsid Protein Proteine

Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität SARS Coronavirus (SARS-CoV)
Source HEK-293 Cells
Validierungen
  • (2)
Kat. Nr. ABIN7013145
Menge 100 μg
Datenblatt Datenblatt
Reaktivität SARS Coronavirus (SARS-CoV)
Source Escherichia coli (E. coli)
Validierungen
Kat. Nr. ABIN7197788
Menge 50 μg
Datenblatt Datenblatt
Reaktivität SARS Coronavirus (SARS-CoV)
Source Escherichia coli (E. coli)
Validierungen
Kat. Nr. ABIN7385288
Menge 20 μg
Datenblatt Datenblatt

Neueste Publikationen zu unseren SARS-Coronavirus Nucleocapsid Protein Produkten

Du, Deiter, Bouzidi, Billaud, Simmons, Dabral, Selvarajah, Lingappa, Michon, Yu, Paulvannan, Manicassamy, Lingappa, Boushey, Greenland, Pillai: "A viral assembly inhibitor blocks SARS-CoV-2 replication in airway epithelial cells." in: Communications biology, Vol. 7, Issue 1, pp. 486, (2024) (PubMed).

Weingarten-Gabbay, Chen, Sarkizova, Taylor, Gentili, Hernandez, Pearlman, Bauer, Rice, Clauser, Hacohen, Carr, Abelin, Saeed, Sabeti: "The HLA-II immunopeptidome of SARS-CoV-2." in: Cell reports, Vol. 43, Issue 1, pp. 113596, (2024) (PubMed).

Brogna, Bisaccia, Costanzo, Lettieri, Montano, Viduto, Fabrowski, Cristoni, Prisco, Piscopo: "Who Is the Intermediate Host of RNA Viruses? A Study Focusing on SARS-CoV-2 and Poliovirus." in: Microorganisms, Vol. 12, Issue 4, (2024) (PubMed).

Gallucci, Bazire, Davidson, Shytaj: "Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro." in: Antiviral research, Vol. 221, pp. 105766, (2024) (PubMed).

Bagato, Balkema-Buschmann, Todt, Weber, Gömer, Qu, Miskey, Ivics, Mettenleiter, Finke, Brown, Breithaupt, Ushakov: "Spatiotemporal analysis of SARS-CoV-2 infection reveals an expansive wave of monocyte-derived macrophages associated with vascular damage and virus clearance in hamster lungs." in: Microbiology spectrum, Vol. 12, Issue 1, pp. e0246923, (2024) (PubMed).

Barlang, Deimel, Mohl, Blaurock, Balkema-Buschmann, Weinbender, Hess, Obernolte, Merkel, Popp: "Distribution and suitability of pulmonary surfactants as a vehicle for topically applied antibodies in healthy and SARS-CoV-2 infected rodent lungs." in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Vol. 196, pp. 106744, (2024) (PubMed).

Datta, Chen, Tavares, Reyes-Robles, Ryu, Khan, Bechtel, Bertoch, White, Hazuda, Vora, Hett, Fadeyi, Oslund, Emili, Saeed: "High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface." in: Cell chemical biology, Vol. 30, Issue 10, pp. 1313-1322.e7, (2023) (PubMed).

Stüdle, Nishihara, Wischnewski, Kulsvehagen, Perriot, Ishikawa, Schroten, Frank, Deigendesch, Du Pasquier, Schirmer, Pröbstel, Engelhardt: "SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier." in: Fluids and barriers of the CNS, Vol. 20, Issue 1, pp. 76, (2023) (PubMed).

Vanderlinden, Boonen, Noppen, Schoofs, Imbrechts, Geukens, Snoeck, Stevaert, Naesens, Andrei, Schols: "PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding." in: Antiviral research, Vol. 217, pp. 105700, (2023) (PubMed).

Huang, Fan, Sun, Yang, Zhang, Wang, Li, Zhang, Zhang, Li, Wang, Feng, Zhao, Chen, Qu: "SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril." in: Antiviral research, Vol. 215, pp. 105636, (2023) (PubMed).

Synonyme und alternative Namen zu SARS-Coronavirus Nucleocapsid Protein

nucleocapsid protein (N), NC, Protein N

Bezeichner auf Proteinebene für SARS-Coronavirus Nucleocapsid Protein

  • Nucleocapsid protein
Sie sind hier:
Kundenservice